Concordia Healthcare (CXRX) Tops Q2 EPS by 3c

Concordia Healthcare (NASDAQ: CXRX) reported Q2 EPS of $1.04, $0.03 better than the analyst estimate of $1.01. Revenue for the quarter came in at $77.5 million versus the consensus estimate of $84.47 million.

For earnings history and earnings-related data on Concordia Healthcare (CXRX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• Vireo Growth completes acquisition of C21 Investments